Fischer Medical Ventures Ltd — Important, 28-10-2025: Company Update

Fischer Medical Ventures' board has approved the appointment of Mr. Chan Sing En as an Additional Non-Executive Independent Director for five years. Mr. Chan brings over three decades of experience in private equity, corporate finance, and strategic investments across Southeast Asia and Australia. The board also proposes the appointment of Tan Sri Dato’ Dr. Syed Jalaludin as an Independent Director for a five-year term. Dr. Jalaludin is a distinguished academician and leader with over five decades in education, corporate governance, and public sectors in Malaysia. Both appointments are pending shareholder approval, aiming to strengthen the board's expertise and strategic oversight.